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An increasing number of centers not necessarily equipped with biplane (BP) angiosuites are performing 
mechanical thrombectomy (MT) in acute ischemic stroke patients. We assessed whether MT performed 
on single-plane (SP) is equivalent in terms of safety, effectiveness, radiation and contrast agent 
exposure. Consecutive patients treated by MT in four high volume centers between January 2014 and 
May 2017 were included. Demographic and MT characteristics were assessed and compared between 
SP and BP. Of 906 patients treated by MT, 576 (64%) were handled on a BP system. After multivariate 
analysis, contrast load and fluoroscopy duration were significantly lower in the BP group [100vs200mL, 
relative effect 0.85 (CI: 0.79–0.92), p = 0.0002; 22 vs 27 min, relative effect 0.84 (CI: 0.76–0.93), 
p = 0.0008, respectively]. There was no difference in recanalization (modified Thrombolysis-In-Cerebral-
Infarction 2b-3), good clinical outcome (modified Rankin Scale 0–2), complications rates, procedure 
duration or radiation exposure. A three-vessel diagnostic angiogram performed prior to MT led to a 
significant increase in procedure duration (15% increase, p = 0.05), radiation exposure (33% increase, 
p < 0.0001) and contrast load (125% increase, p < 0.0001). Mechanical neuro-thrombectomy seems 
equally safe and effective on a single or biplane angiography system despite increased contrast load and 
fluoroscopy duration on the former.
Multiple randomized controlled trials have demonstrated the benefits of cerebrovascular mechanical thrombec-
tomy (MT) in acute ischemic stroke patients with emergent large vessel occlusion (AIS-ELVO)1–6. Two further 
randomized trials evaluating late-onset strokes with favorable perfusion imaging7,8, have broadened its indica-
tions9,10. Adequate training is necessary for these procedures, which are often more complicated than may be 
anticipated11,12. Most neuro-interventionalists prefer working on biplane (BP) angiosuites since two simultaneous 
projections of the material and anatomical structures per contrast injection tends to reduce the risk of arte-
rial perforation compared to single plane (SP) procedures12,13. Nonetheless, X-ray and contrast agent exposure 
remain a major public health concern in terms of carcinogenesis14–17, risk of renal failure18–20 or toxic reactions, 
respectively21,22.
Since an increasing number of centers are performing MT12 in the context of ELVO without necessarily being 
equipped with BP angiosuites, there is a need to understand whether MT performed on SP is equivalent in terms 
of safety, effectiveness, radiation and contrast agent exposure22.
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Since evidence regarding safety and effectiveness of MT on SP and BP is contradictory18,23–25, we performed 
a multicentric analysis based on prospectively acquired data from four internationally accredited comprehensive 
stroke centers to establish which variables are associated with an increased radiation or contrast exposure during MT.
Results
Baseline characteristics. Of the 906 MT included, 330 (36%) and 576 (64%) were performed on SP and BP 
systems, respectively. Baseline characteristics did not differ significantly (see Table 1 for details) for clinical, imag-
ing and interventional characteristics. For additional details, please check on-line supplemental material. Mean 
age was 69 ± 15 years (range: 18–100). Median National Institute of Health Stroke Scale (NIHSS) at admission 
was 17 (Interquartile range or IQR 12–21).
Procedure duration. All procedures were performed within 6 hours of stroke onset according to interna-
tional recommendations26.
Time from stroke onset to groin puncture as well as procedure time (from initial groin puncture to last image 
in minutes) are described for all patients and did not differ significantly.
Statistical analysis. After multivariate analyses, there was no significant difference in rates of successful 
recanalization, periprocedural complication, nor for DAP or air kerma (Tables 1 and 2), whereas contrast load 
and fluoroscopy duration remained significantly lower on BP compared to SP interventions [100 vs 200 mL (50% 
decrease, relative effect 0.85,CI: 0.79–0.92, p = 0.0002) and 22 vs 27 min (19% decrease, relative effect 0.84, CI: 
0.76–0.93, p = 0.0008), respectively].
There was no significant difference in rates of good clinical outcome (mRS 0–2) between BP and SP (40.1% 
versus 50%, p = 0.22 after multivariate analyses).
Factors associated with increased dose or contrast. Three variables were independently associated 
with an increased DAP, kerma and contrast load, namely cervical dissection as ELVO etiology (207 Gy.cm² vs 148 
for other stroke etiology p < 0.0001), tandem occlusion (239 Gy.cm² vs 148 for other occlusion types p < 0.0001) 
or the need for stenting and/or angioplasty (271 Gy.cm² vs 137 without angioplasty or stenting, p < 0.0001). Use 
of a stent-retriever and general anesthesia were associated with increased radiation dose in univariate but not in 
multivariate analyses.
After adjustment for potential confounders, a three or four vessel diagnostic cerebral angiogram before MT 
significantly increased radiation dose: DAP 161 Gy.cm² vs 122 without diagnostic angiograms (33% increase, 
p < 0.0001). The same effect was observed for contrast load and procedure duration: 180 vs 80 mL (125% increase, 
p < 0.0001) and 46 vs 40 minutes (15% increase, p = 0.05), respectively, without affecting the rates of successful 
recanalization, periprocedural complication or good clinical outcome.
Discussion
According to our multicentric data, MT performed on BP does not improve efficacy or safety compared to SP 
interventions, despite the added subjective sense of comfort acknowledged by the majority of operators (which 
was not specifically measured).
Overall, biplane use significantly reduced contrast load (50% decrease, p < 0.0001) and fluoroscopy duration 
(19% decrease, p = 0.0056). DAP and kerma, however, were not affected after adjusting for potential confounders, 
contrary to the effect of radiation reduction dose-systems as showed in the literature27.
Likewise, rates of successful recanalization, periprocedural complications, good functional outcome and 
total procedure duration did not differ between BP and SP interventions. As expected, more complex and 
time-consuming interventions, such as those associated with cervical dissection, tandem occlusions28, stent-
ing and/or angioplasty were associated with increased contrast load and radiation doses. Use of stent-retriever, 
contact aspiration29, general anesthesia or conscious sedation30 were associated with similar rates of safety and 
effectiveness. Despite increased radiation exposure with stent-retrievers use or general anesthesia in univariate 
analyses, this was no longer significant after multivariate analysis.
Our results contradict a recent literature review suggesting reduced radiation, contrast load, risk of complica-
tions and procedure duration with biplane angiosuites13. As recognized by the authors of the latter, however, the 
level of evidence was low. Moreover, MT was not the sole intervention studied, as opposed to the data present. It is 
noteworthy that neurointerventional procedures31, when compared to coronary angioplasty18 and angiography32, 
may be associated with a lower DAP on BP systems.
Based on the higher acquisition and maintenance costs of BP systems and the absence of an obvious clinical 
benefit for MT13, there is currently no evidence to recommend performing such procedures exclusively on BP 
or to withhold MT from SP systems. One could even argue that the latter appears to be more cost-effective and 
that the number of treatment sites capable of offering MT could be expanded if BP is not mandatory. One should 
emphasize, however, that our data was acquired only in high-volume academic centers with expertly trained 
operators, meaning our results do not necessarily apply to other clinical settings33.
Although some physicians believe that a three or four vessel diagnostic cerebral angiogram, including both inter-
nal carotid arteries and at least the dominant vertebral artery, is essential before performing MT, mainly to assess all 
collateral flow routes34, our results indicate that this may be more harmful by increasing contrast load, procedure 
duration and radiation exposure unnecessarily. Although the additional diagnostic runs do not negatively influ-
ence clinical outcome, collateral flow is nowadays sufficiently well assessed on admission computed-tomography 
or magnetic-resonance-imaging, especially when advanced imaging such as multiphase computed-tomography 
angiogram or perfusion studies are performed35. Moreover, additional diagnostic runs are unlikely to modify the 
therapeutic approach in the vast majority of situations, since thrombectomy will be attempted as long as an ELVO 
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Angioroom Type All n (%) Single-plane Imaging n (%) Biplane Imaging n (%)
Number (Total 906) 906 (100) 330 (36.4) 576 (63.6)
Center*
   A 126 38 (11.5) 88 (15.3)
   B 488 179 (54.2) 309 (53.6)
   C 151 0 (0) 151 (26.2)
   D 141 113 (34.2) 28 (4.9)
Dates*
   January-December 2014 207 (23) 119 (36) 88 (15)
   January-December 2015 462 (51) 157 (48) 305 (53)
   January 2016-May 2017 237 (26) 54 (16) 183 (32)
Gender
   Male 444 157 (52.4) 287 (49.8)
   Female 462 173 (47.6) 289 (50.2)
Age (years): Median, Q1, Q3* 72 (59–81) 69 (58–80) 72 (59–82)
Weight (kg): Median, Q1, Q3 75 (65–85) 75 (63–84) 75 (65–86)
Pre-stroke mRS: Median, Q1, Q3 0 (0–1) 0 (0–0) 0 (0–1)
Onset NIHSS: Median, Q1, Q3 17 (12–21) 17 (11–21) 17 (12–20)
Supra-Aortic imaging
   Yes 572 208 (63) 364 (63.2)
   No 334 122 (37) 212 (36.8)
Side
   Right 375 131 (40) 244 (42.4)
   Left 465 174 (53) 291 (50.5)
   Midline (Basilar artery) 66 25 (7) 41 (7.2)
Level of Occlusion
   MCA-M1 473 170 (51.5) 303 (52.6)
   MCA- M2 117 38 (11.5) 79 (13.7)
   Terminal ICA 157 60 (18.2) 97 (16.8)
   Tandem 93 37 (11.2) 56 (9.7)
   Basilar artery 66 25 (7.6) 41 (7.1)
Intravenous thrombolysis
   Yes 639 257 (77.9) 382 (66.3)
   No 267 73 (22.1) 194 (33.7)
Anesthesia*
   General (GA) 307 131 (39.7) 176 (30.6)
   Conscious Sedation (CS) 578 194 (58.8) 384 (66.7)
   CS converted in AG 21 5 (1.5) 16 (2.8)
Pre-intervention angiogram*
   Yes 609 279 (84.5) 330 (57.3)
   No 297 51 (15.4) 246 (42.7)
Technique*
   Stent-retriever 374 188 (57) 186 (32.3)
   Aspiration 348 120 (36.4) 228 (39.6)
   Combined 184 22 (6.7) 162 (28.1)
Stenting and/or angioplasty
   Yes 129 52 (15.8) 77 (13.4)
   No 777 278 (84.2) 499 (86.6)
Stroke etiology*
   Cardio-embolic 423 106 (48.9) 317 (57.9)
   Atherosclerosis 126 39 (18) 87 (15.9)
   Dissection 38 13 (6) 25 (4.6)
   Other 178 59 (27.2) 119 (21.7)
Stroke onset to groin (min): Median (Q1, Q3) 244 (230–275) 254 (218–282) 239 (226–273)
Table 1. Description of single and biplane groups. *Significant difference between groups, p < 0.05, used in the 
multivariate regression. BP: Biplane angiosuite. CS: Conscious Sedation. GA: General Anesthesia. MCA-M1: 
First portion of the Middle Cerebral Artery. MCA-M2: Second portion of the Middle Cerebral Artery. MT: 
Mechanical Thrombectomy. N: Number. NIHSS: National Institute of Health Stroke Scale. Q1: First quartile. 
Q3: Third quartile. SP: Single-Plane/Mono-plane angiosuite. TICI: Thrombolysis In Cerebral Infarction score.
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is still present. Lastly, the cumulative radiation dose from DSA, computed-tomography, computed-tomography 
perfusion and angiography prior to MT should be minimized as much as possible.
Our study is the first to compare SP and BP with such a high number of patients, international centers and 
focusing on a large variety of both technical and clinical outcomes. Our approach let us describe a game-changing 
result in the assessment of collateral flow, showing that invasive assessment of a four vessel diagnostic cerebral 
angiogram before a MT procedure could be more harmful for patients than useful.
We do believe the SP versus BP comparison is a major issue when more and more centers tend to treat patients 
for MT. Whether facilities without biplane systems are able to perform MT whether the installation of a biplane 
system is required are major organizational issues.
Lastly, on the contrary to a recent similar analysis36, our results emphasized the importance of both AP and lat-
eral views in interventional neuroradiology, showing a complete different technical approach than Friedrich&al. 
Their results showed a similar contrast load with twice the radiation dose for biplane angiosuites, implying they 
performed the same number of runs on SP and BP: the second view was not useful for them. In these circum-
stances, rates of complication and successful recanalisations they describe may be difficult to grasp and interpret 
knowing the low level of evidence of a study with less than 200 patients.
Limitations. There were several limitations due to the retrospective nature of our study. Exposure related 
to flat panel computed tomography following MT completion (mainly to evaluate vessel perforation in selected 
cases) may have unduly increased the mean DAP. Given the low total number of complications, however, this 
appears to be insignificant. Secondly, the cumulative dose of patients screened with CT at admission was not 
incorporated in our analyses, although the proportion screened with this modality in the BP and SP population 
were similar. Thirdly, while individual skills, experience, speed and radioprotection knowledge may differ from 
one center to the next or within a given institution and influence the results, it is unlikely to have played a signif-
icant role considering the similar experience, fellow involvement and interventional protocols in the four partic-
ipating comprehensive stroke centers. Fourthly, estimation of reperfusion success, self-assessed by non-core-lab 
adjudicated mTICI evaluations, may have incorporated suboptimal single-plane evaluations with possible miss-
ing antero-posterior or lateral views before and after recanalization. Fifthly, the SP and BP arms were unbalanced 
and not primarily randomized to study their performance for MT, our results may then be limited, randomized 
trials would be necessary to assess this matter. A relatively high number of patients between 2015 and 2017 were 
treated on upgraded angiosuites equipped with dose reduction technologies, they were not included in the pres-
ent study to avoid bias in radiation doses analyses, the impact of dose reduction technology was not evaluated. 
The scale to report the amount of contrast agent administered was not specifically described for each center 
however, inclusion of centers in the multivariate analysis may have limited bias. Lastly, number of attempts and 
number of devices used for MT were not reported in our study.
Conclusion
Mechanical neuro-thrombectomy seems equally safe and effective on a single or biplane angiography system, 
despite increased contrast load and fluoroscopy duration on the former, especially if a three or four vessel 
pre-interventional diagnostic angiogram is performed.
Materials and Methods
The study protocol was approved by the institutional review board of each of the four certified comprehensive 
stroke centers in France, Switzerland and the United States of America (See Supplemental material). Patient 
informed consent was waived for this retrospective analysis of pooled anonymized prospectively acquired data. 
Adherence to the STROBE criteria37 and compliance with the Health Insurance Portability and Accountability 
Act were enforced.
Angioroom Type
Single-plane 
Imaging n (%)
Biplane 
Imaging n (%)
p -value 
univariate
 p-value 
multivariate
Number (906 total) 330 (36.4) 576 (63.6)
Recanalization rate (TICI 2b-3) 280 (84.8) 480 (83.3) 0.57 0.53
Complication rate % 52 (15.8) 89 (15.4) 0.92 0.54
Procedure delay (min): Median, Q1, Q3 45 (30–71) 44 (30–73) 0.64 0.72
24h NIHSS: Median, Q1, Q3 11 (4–19) 12 (4–20) 0.47 0.47
3 months good mRS (0–1–2) 165 (50.0) 231 (40.1) <0.0001 0.22
DAP Gy.cm²: Median, Q1, Q3 170 (106–280) 140 (92–235) 0.0001 0.57
Kerma Gy: Median, Q1, Q3 0.96 (0.6–1.9) 0.97 (0.6–1.7) 0.38 0.13
Contrast load mL: Median, Q1, Q3 200 (150–250) 100 (60–180) <0.0001 0.0002
Scopy duration min: Median, Q1, Q3 27 (17–41) 22 (14–37) 0.00012 0.0008
Table 2. Uni and multivariate results of the single versus biplane comparison. BP: Biplane angiosuite. cm.²: 
centimeter square. DAP: Dose–Area Product. Gy.cm²: Gray per centimeter square. mL: milliliter’s. mRS: 
modified Rankin Scale. MT: Mechanical Thrombectomy. N: Number. NIHSS: National Institute of Health 
Stroke Scale. Q1: First quartile. Q3: Third quartile. SP: Single-Plane/Mono-plane angiosuite. TICI: Thrombolysis 
In Cerebral Infarction score.
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Population. All consecutive patients who underwent MT for AIS-ELVO confirmed by magnetic- 
resonance-imaging or computed-tomography38,39 between January 2014 and May 2017 on a biplane (BP) or 
single-plane (SP) angiosuite were included.
Functional outcome using the modified Rankin Scale (mRS)40 was assessed at 90 days by a certified stroke 
neurologist.
Over the 3-year study period, fellow involvement ranged from assistance to supervised or fully independent 
MT but was not recorded.
Dose metrics. Variables assessed were Kerma (Gy), dose-area product (DAP) (Gy.cm²) and total fluoroscopy 
time (minutes).
Imaging system parameters. The technical parameters of each angiosuite (see Supplement Tables 1 and 2) 
were reported and verified by two radio-physicists (F.C. and S.M.). A 27 or 32 cm field-of-view was used for the 
vast majority of treatments. DAP, kerma and fluoroscopy duration were extracted from the dose reports of the 
picture archiving systems by one of the local interventional neuro-radiologist or medical physicist. Angiosuites 
were regularly calibrated and controlled according to national and international standards.
Statistics/data analysis. The primary outcome was the rate of good functional outcome at 90 days (defined 
as a mRS of 0 to 2) dichotomized into SP and BP interventions.
Secondary outcome measures were rates of successful recanalization (defined as modified Thrombolysis In Cerebral 
Infarction score [mTICI] 2b or 3), complications (periprocedural perforation, hemorrhage, and iatrogenic thromboem-
bolic events), procedure and fluoroscopy time (from initial groin puncture to last image), total radiation dose (air kerma 
and DAP) and contrast agent volume injected in SP versus BP then depending on the angiosuite brand. Furthermore, 
we assessed which variables were associated with an increased radiation or contrast load during MT.
Since MT focuses on the head and neck region, we assumed there was no need to correct for automated 
weight-adapted variation of radiation dose, as occasionally described41–43. Nonetheless, the absence of interaction 
with all variables was statistically tested.
A descriptive analysis was first performed. Categorical variables were summarized using frequency, individual 
and cumulative percentages. Continuous variables were expressed by mean, standard deviation, quartiles and 
interquartile range. Shapiro-Wilk tests served to test the normality of the continuous variables. The eight variables 
of interest (mTICI, mRS at 3 months, periprocedural complication rate, scopy duration, procedure duration, DAP, 
kerma and contrast load) were compared and dichotomized according to angiosuite type (SP or BP) using the 
Mann-Whitney or Fisher test for continuous or categorical variables, respectively. Then, to eliminate the effect 
of potential confounders, eight different models were tested. For continuous variables, a linear regression with 
logarithmically transformed variables was finally used after having checked that residual plots did not deviate 
from normality. For binary variables, we used a logistic regression. Potential confounders were determined based 
on a previous literature review. To retain only the most significant, a univariate analysis with the Mann-Whitney 
tests for quantitative variables and a Fisher exact test for qualitative variables was performed. Only variables 
showing a statistically significant difference were finally selected as potential confounders in the multivariate 
models. Multiple regression was used to adjust for age, number of pre-interventional angiograms, anesthesia 
type (conscious sedation or general anesthesia), MT technique (stent-retriever, contact aspiration, combination 
thereof), center, etiology and date of the intervention. Bonferroni correction was used to minimize inflation of 
type I error for the eight independent models used. We used the R Statistical Software (version 3.4.2, Foundation 
for Statistical Computing, Vienna, Austria) for all statistical analyses.
Statistical analysis. Kevin ZUBER (MSc) conducted all the statistical analyses.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable 
request.
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